SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-177895
Filing Date
2008-08-14
Accepted
2008-08-14 12:52:30
Documents
9
Period of Report
2008-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 664740
2 AMENDMENT AGREEMENT dex104.htm EX-10.4 23971
3 SUBSIDIARIES OF THE REGISTRANT dex21.htm EX-21 6548
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ERNST & YOUNG LLP dex23a.htm EX-23.(A) 1724
5 POWER OF ATTORNEY dex242.htm EX-24.2 13566
6 SECTION 302 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER dex311.htm EX-31.1 8893
7 SECTION 302 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER dex312.htm EX-31.2 8899
8 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 dex32.htm EX-32 4324
9 GRAPHIC g10632linechart.jpg GRAPHIC 32711
  Complete submission text file 0001193125-08-177895.txt   779262
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

IRS No.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 10-K | Act: 34 | File No.: 000-17988 | Film No.: 081016975
SIC: 2835 In Vitro & In Vivo Diagnostic Substances